BOULDER, Colo.--(BUSINESS WIRE)--Crestone, Inc. (“Crestone”) today announced positive topline results from the Phase 2 clinical trial evaluating CRS3123 in patients with Clostridioides difficile ...

Same stuff, different day? Dr Tamaan Osbourne-Roberts explores the development of the 2026 dietary guidelines and what it actually means for patient care.

Anthropic launches Code Review for Claude Code, a multi-agent AI system that audits pull requests for bugs at $15–$25 per review, as the company sues the Trump administration over a Pentagon “supply ...